Business Wire Press Releases Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 Aug 14, 2026
Business Wire Press Releases Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 Business Wire Press Release Aug 14, 2026 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-ge…
Business Wire Press Releases Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 Aug 5, 2026
Business Wire Press Releases Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 Business Wire Press Release Aug 5, 2026 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel n…
Business Wire Press Releases Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network Jul 29, 2026
Business Wire Press Releases Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network Business Wire Press Release Jul 29, 2026 SEATTLE--(BUSINESS WIRE)-- Parse Biosciences, the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, to…
Business Wire Press Releases Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development Jul 28, 2026
Business Wire Press Releases Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development Business Wire Press Release Jul 28, 2026 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel n…
Business Wire Press Releases Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network Jul 15, 2026
Business Wire Press Releases Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network Business Wire Press Release Jul 15, 2026 SEATTLE--(BUSINESS WIRE)-- Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announ…
